BTG3 and systemic sclerosis: In accordance with the results from a study conducted by Hamaguchi et al. [55] as well as the German network for SSc [43], Salazar et al. found that ANA-negative patients less likely present vasculopathic features of the disease such as digital ulcerations, telangectasia as well as PH [31].